menu
Board
Our Governing Board is composed of 9 members with profiles combining experience in the area of pharmaceuticals and biotech and Orano's expertise in the nuclear sector.
Our Governing Board
Guillaume Dureau
Directeur de la BU Projets - Directeur de la R&D et de l’Innovation
Find out more
Arnaud Lesegretain
President and Chief Executive Officer of Orano Med
Find out more
Fabrice Chouraqui
CEO-Partner at Flagship Pioneering
Find out more
Frédéric Desdouits
CEO of Treefrog Therapeutics
Find out more
Thierry Laugel
CEO and Managing Partner at Kurma Partners
Find out more
Michael McMurphy
Nuclear Energy Expert
Find out more
David Claverie
Chief financial Officer of the Orano Group
Find out more
Nicolas Maes
Chief Executive Officer of the Orano Group
Find out more
Simon Segal
Senior Executive Vice President of Strategy, Mergers and Acquisitions of the Orano Group
Find out more